Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromide interference: is less really better?

K Emancipator1, M H Kroll

  • 1National Institutes of Health, Warren G. Magnuson Clinical Center, Bethesda, MD 20892.

Clinical Chemistry
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Endothelium-derived Relaxing Factor Inhibits Shear Stress-induced Platelet Aggregation.

Platelets·2010
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
Same journal

Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

Clinical chemistry·2026
Same journal

In Reply to Reflexing NT-proBNP for sFlt-1/PlGF Ratios That Fall into the Measurement Uncertainty for Preeclampsia Risk Classification.

Clinical chemistry·2026
See all related articles

Elevated serum bromide, often from drugs or environmental factors, can be detected. Analyzing chloride interference across different lab analyzers can help confirm bromide toxicity and measure its concentration.

Area of Science:

  • Clinical Chemistry
  • Toxicology
  • Analytical Chemistry

Background:

  • Increased serum bromide levels can stem from drug ingestion and environmental exposures.
  • Chloride assays with low bromide interference may mask bromide toxicity, hindering clinical suspicion.
  • Bromide interference varies among different laboratory analyzers.

Purpose of the Study:

  • To explore the diagnostic utility of bromide interference in clinical chemistry analyzers.
  • To investigate methods for confirming bromide toxicity when suspected.
  • To estimate serum bromide concentration by leveraging inter-analyzer bromide interference.

Main Methods:

  • Comparative analysis of bromide interference across multiple clinical chemistry analyzers.
  • Evaluation of chloride assay methodologies for bromide susceptibility.

Related Experiment Videos

  • Correlation of analyzer-specific interference patterns with suspected bromide toxicity.

    • Main Results:

    • Significant variations in bromide interference were observed among different automated analyzers.
    • The degree of interference correlated with the potential for detecting elevated serum bromide.
    • Analyzer-specific interference patterns can serve as a diagnostic indicator for bromide toxicity.

    Conclusions:

    • Differences in bromide interference among analyzers can be exploited for diagnostic purposes.
    • This approach aids in confirming suspected bromide toxicity.
    • It provides a method for estimating serum bromide concentrations in clinical toxicology.